Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Unknown 2Completed 1

Sponsor Class

UNKNOWN 1OTHER 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 17Gastrointestinal 14Head & Neck 10Sarcoma 3Lymphoid 3Dermatologic 3Gynecologic 2CNS 2Breast 1

Conditions

Sarcoma 2Osteosarcoma 1

Interventions

Cyclophosphamide 93Doxorubicin 92Radiotherapy 87Temozolomide 69Filgrastim 58Ifosfamide 55Bevacizumab 55Etoposide 48Gemcitabine 44Imatinib Mesylate 43Vincristine 40pembrolizumab 35pazopanib 34Peripheral Blood Stem Cell Transplantation 31Methotrexate 31Nivolumab 30Carboplatin 30fludarabine phosphate 29Irinotecan 29Cisplatin 28Paclitaxel 26Melphalan 26Magnetic Resonance Spectroscopy 26Docetaxel 25Busulfan 25Trabectedin 24apatinib 22Specimen Handling 21Sirolimus 21Antilymphocyte Serum 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × endostar protein × Sarcoma × Clear all
NCT03121833 2019-12-26

Endostar Combined With Chemotherapy for Stage â…£ Soft Tissue Sarcoma

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Completed
52 enrolled
Sarcoma

Sarcoma

NCT01002092 2014-09-03

A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma

Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd

Phase 2 Unknown
160 enrolled
Sarcoma

Osteosarcoma

NCT01812018 2013-03-15

Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma

ChineseAMS

Phase 2 Unknown
30 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡